FDA OKs Antibody-Drug Conjugate for Bladder Cancer
Accelerated approval for enfortumab vedotin in post-checkpoint setting
Related Articles
American Kids’ Health Has Been Declining, Study Finds
Researchers point to a need to ‘address underlying systemic factors’
Large Study Shows No Ties Between Ever Using Birth Control Pills and Liver Cancer
But risk slightly increased with longer duration of use, meta-analysis suggested
Multilevel Intervention Increased HPV Vaccination for Most Children
However, the most socioeconomically marginalized children saw the least benefit
Higher Education May Be a Double-Edged Sword in Alzheimer’s
Tau accumulated faster in people with brain amyloid who were more educated
Obese Population Swells Under Proposed New Framework
European criteria reclassify nearly 1 in 5 overweight persons as obese
Defrauding Medicare or Medicaid Could Put Citizenship at Risk, DOJ Says
Policy would apply to those who became naturalized citizens by illegal means
Clinical Trial Sheds Light on Daily CBD Use and Liver Enzymes
Some trial participants had peak levels ten times higher than normal upper limit
Blood Tests Predict Dementia in Down Syndrome
Plasma p-tau217 foreshadowed Alzheimer’s pathology and cognitive decline
First Targeted Therapy for Exon 20 Insertions in NSCLC Wins FDA Accelerated Approval
Sunvozertinib achieved a response rate of 46% after progression on platinum-based chemotherapy
Study: Yes, Psoriasis Progression to PsA Can Be Stopped
Risk that psoriasis turns into psoriatic arthritis halved with anti-TNF treatment